An erythema migrans otherwise known as an EM, is the rash associated with Lyme disease. The rash does not occur in every case of Lyme disease but if a patient does present with an EM rash then no blood test is required and treatment should be prescribed immediately as per […]
Read more
‘An Inadequate Tool for Doctors and Patients, Seriously Undermined by Lack of Evidence’ Lyme Disease UK is a registered stakeholder in the NICE Lyme disease guideline writing process. As the UK’s largest patient support network, taking part in this process has been an important priority because once finalised, the guideline […]
Read more
On 23rd February 2016, representatives from Lyme Disease UK attended a scoping workshop hosted by NICE as part of the first stages of the new Lyme disease guidelines formation. The workshop involved an introduction to the guidelines writing process and a chance to meet the chairperson. Group discussions were held […]
Read more
We are delighted to announce that the LDUK Co-Founders have registered as stakeholders for the upcoming National Institute for Health and Care Excellence (NICE) Lyme disease guideline writing process. If any other patient groups or organisations would like to register as stakeholders, please check your eligibility and complete this online […]
Read moreThe International Lyme and Associated Diseases Society (ILADS) have produced new evidence-based guidelines for the management of patients with Lyme disease. The guidelines address three clinical questions; The usefulness of antibiotic prophylaxis for known tick bites The effectiveness of erythema migrans treatment The role of antibiotic retreatment in patients with persistent manifestations of […]
Read more